Підписатись
Jakub Hlávka
Jakub Hlávka
Інші іменаJakub P. Hlávka
Masaryk University, Brno, Czech Republic; USC Schaeffer Center, USC Keck School of Medicine
Підтверджена електронна адреса в usc.edu - Домашня сторінка
Назва
Посилання
Посилання
Рік
Biosimilar cost savings in the United States: initial experience and future potential
AW Mulcahy, JP Hlávka, SR Case
RAND Health Quarterly 7 (4), 2018
2442018
Artificial Intelligence in Healthcare
A Bohr, K Memarzadeh, (editors)
Academic Press, 2020
2092020
Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups
National Academies of Sciences, Engineering, and Medicine
https://nap.nationalacademies.org/read/26479/chapter/1, 2022
912022
Assessing the preparedness of the US health care system infrastructure for an Alzheimer’s treatment
JL Liu, JP Hlávka, R Hillestad, S Mattke
The RAND Corporation, Santa Monica, CA, 2017
912017
Assessing the Preparedness of the Health Care System Infrastructure in Six European Countries for an Alzheimer's Treatment
JP Hlavka, S Mattke, JL Liu
RAND Health Quarterly 8 (3), 2019
842019
Toward a Sustainable Blood Supply in the United States
AW Mulcahy, K Kapinos, B Briscombe, L Uscher-Pines, R Chaturvedi, ...
Santa Monica (CA): RAND Corporation, 2016
612016
Blood‐based biomarkers for Alzheimer's pathology and the diagnostic process for a disease‐modifying treatment: Projecting the impact on the cost and wait times
MH Soeren Mattke, Sang Kyu Cho, Tobias Bittner, Jakub Hlávka
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2020
462020
Macroeconomic consequences of the COVID-19 pandemic
T Walmsley, A Rose, R John, D Wei, JP Hlávka, J Machado, K Byrd
Economic modelling 120, 106147, 2023
332023
Assessing the preparedness of the Canadian health care system infrastructure for an Alzheimer's treatment
J Liu, J Hlávka, D Coulter, SM Baxi, S Mattke, CA Gidengil
RAND, 2019
262019
Security Sector Reform in Ukraine
O Oliker, LE Davis, K Crane, A Radin, CW Gventer, S Sondergaard, ...
RAND Corporation, 2016
232016
The potential emergence of disease-modifying treatments for Alzheimer disease: the role of primary care in managing the patient journey
J Lam, J Hlávka, S Mattke
The Journal of the American Board of Family Medicine 32 (6), 931-940, 2019
212019
US Presence and the Incidence of Conflict
A O’Mahony, BF Miranda Priebe, J Kavanagh, M Lane, T Johnston, ...
RAND Corporation, 2018
212018
Security, privacy, and information-sharing aspects of healthcare artificial intelligence
JP Hlávka
Artificial Intelligence in Healthcare, 235-270, 2020
202020
Challenges to the Sustainability of the US Public Cord Blood System
KA Kapinos, B Briscombe, T Gracner, A Strong, C Whaley, E Hoch, ...
RAND Corporation, 2017
192017
Targeted interoperability: a new imperative for multinational operations
CG Pernin, J Hlávka, ME Boyer, J Gordon, J Osburg, M Lerario, M Shurkin, ...
RAND, 2019
152019
Lessons from Others for Future US Army Operations in and Through the Information Environment
C Paul, CP Clarke, M Schwille, JP Hlávka, MA Brown, SS Davenport, ...
RAND Corporation, 2018
152018
3D printing: Downstream production transforming the supply chain
S Veronneau, G Torrington, JP Hlávka
RAND Corporation Santa Monica United States, 2017
13*2017
Assessing the preparedness of the Japanese health care system infrastructure for an Alzheimer’s treatment
S Mattke, J Hlávka, J Yoong, M Wang, R Goto
112019
The economics of alternative payment models for pharmaceuticals
JP Hlávka, JC Yu, DP Goldman, DN Lakdawalla
The European Journal of Health Economics 22, 559-569, 2021
102021
Biosimilar cost savings in the United States
AW Mulcahy, JP Hlávka, SR Case
Rand Corporation Perspective, 2017
92017
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20